The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
among universities worldwide for producing undergrad entrepreneurs
locations
companies founded by graduates and faculty in the last 10 years
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Pictured Above / L to R: Professor Naama Brenner, Professor Omri Barak and Aseel Shomar.
In a revolutionary new discovery, Technion researchers Aseel Shomar, Professor Omri Barak, and Professor Naama Brenner propose that cancer cells are able to learn and adapt to changing environments in order to survive. Equipped with this knowledge, researchers are now investigating better ways of treating — and perhaps curing — cancer.
It is commonly thought that both drug resistance and the ability to metastasize appear in cancer cells as random mutations. Since such a mutation is advantageous to cancer cells, enabling them to survive in an environment that attempts to fight them, these mutations become dominant. However, mounting evidence from research groups around the world do not seem to match this hypothesis, and treatment plans based on this theory do not significantly increase patients’ life expectancy. Now, Aseel Shomar, Prof. Barak, and Prof. Brenner propose a new hypothesis that matches the evidence at hand: cancer cells learn and adapt to their environment, enabling them to develop drug resistances and conform to the new environments of metastasis locations.
While cancer cells have no brain, they are sensitive to stress, and seek ways of reducing stress through a trial-and-error process within their gene regulatory network. An interaction that reduces stress gets strengthened.
While tumors that learn and adapt might sound like a nightmare, Ms. Shomar, Prof. Barak, and Prof. Brenner also found reason for hope. The same mutations found to promote cancer in our body can be carried by cells that remain healthy. Even cells from active tumors, transported into healthy tissue, were in some experiments “cured,” reverting to their non-cancerous state.
“There is an interaction between the individual cell and the tissue,” Prof. Brenner explains. “The cell has the capacity to explore, but the tissue imposes order and stability. Cancer could perhaps be treated through strengthening the tissue’s ability to calm and control the pre-cancerous cell.” A better understanding of the system, such as the three provide, is a crucial step towards developing more effective treatments.
Most scientific studies add a titbit of data to an existing framework. This is one of a rare category of studies that re-examine existing data and propose a novel framework, offering answers to questions that had hitherto remained unanswered, and opening up new avenues of exploration.
April 08, 2022
Examine the insights into cancer cells' adaptability, which researchers believe may provide new pathways for effective treatment.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
An Israeli medical researcher has helped shed new light on a mystery that has endured for nearly 340 years: what killed Queen Christina of Sweden, one of 17th-century Europe’s most unusual monarchs. Prof. Zaid Abassi of the Technion – Israel Institute of Technology’s, Ruth and Bruce Rappaport Faculty of Medicine and Rambam Health Care Campus, […]
Artificial intelligence is rapidly becoming an integral part of our lives, and a working tool for professionals in a variety of fields, including medicine, which integrates AI in order to reach faster, more accurate, and more efficient diagnoses. But to what extent can AI truly be relied upon when it comes to complex medical decisions? […]
Few medical decisions seem so simple, yet create so much uncertainty: Is the infection bacterial, and therefore potentially in need of antibiotics, or viral, meaning antibiotics will not help? For years, physicians have tried to answer that question using symptoms, blood tests and tests that directly search for the virus or bacteria. Israeli company MeMed […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.